EUVIMEDEUVIMED entdecken
Crossref

Metabolic Reprogramming in the Aging Heart: Mechanisms, Cellular Senescence, and Translational Perspectives

Aging and Disease · 2026

DOI: 10.14336/ad.2026.1042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging and Disease, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac aging is increasingly recognized as a coordinated process of metabolic reprogramming rather than a passive decline in energy production. This Review synthesizes current evidence linking altered substrate utilization, mitochondrial dysfunction, nicotinamide adenine dinucleotide (NAD⁺) depletion, nutrient-sensing imbalance, metabolism-dependent epigenetic remodeling, and cellular senescence to age-related cardiac vulnerability. Aging myocardium exhibits reduced flexibility in fatty acid and glucose oxidation, context-dependent ketone utilization, defective mitochondrial dynamics and mitophagy, and progressive redox disruption; impaired branched-chain amino acid catabolism is more clearly established in failing hearts than in naturally aged myocardium. These metabolic abnormalities interact with the mechanistic target of rapamycin complex 1 (mTORC1), AMP-activated protein kinase (AMPK), and sirtuin networks, converting transient energetic stress into persistent transcriptional and inflammatory programs. Metabolite-sensitive chromatin modifications and the senescence-associated secretory phenotype further reinforce mitochondrial injury, fibrosis, and paracrine dysfunction across cardiomyocytes, fibroblasts, endothelial cells, and immune cells. We also evaluate emerging translational tools, including epigenetic and metabolomic aging clocks, senescence-associated biomarker panels, NAD⁺ precursors, mTOR modulators, AMPK-activating interventions, senolytics, targeted delivery systems, and cell-based therapies. Although many interventions improve cardiac phenotypes in preclinical models, translation remains limited by insufficient validation in naturally aged human myocardium, cell-type heterogeneity, sex- and disease-stage-dependent responses, and the absence of standardized cardiac aging endpoints. A system-level framework integrating metabolic state, biological age, and residual cardiac resilience may enable more precise prevention and treatment of aging-related cardiovascular disease.

Zitieren

APA

(2026). Metabolic Reprogramming in the Aging Heart: Mechanisms, Cellular Senescence, and Translational Perspectives. Aging and Disease. https://doi.org/10.14336/ad.2026.1042

Vancouver

Metabolic Reprogramming in the Aging Heart: Mechanisms, Cellular Senescence, and Translational Perspectives. Aging and Disease. 2026. doi:10.14336/ad.2026.1042

BibTeX
@article{euvimed2026,
  title = {Metabolic Reprogramming in the Aging Heart: Mechanisms, Cellular Senescence, and Translational Perspectives},
  journal = {Aging and Disease},
  year = {2026},
  doi = {10.14336/ad.2026.1042}
}
Kostenlos starten →